
New real-world studies show Vraylar boosts depression relief, functioning, and quality of life in MDD and bipolar I patients beyond clinical trials.
The bipolar diagnosis introduces some unique aspects to violence prevention and management, although the general principles are similar to those for patients with other psychiatric disorders. More in this slideshow.
 Related content:For more on this topic please see “Violence in Bipolar Disorder,” by Allison M. R. Lee, MD and Igor I. Galynker, MD, PhD, on which this slideshow is based.
